dendritic cells loaded with 17 antigens
Vaccineexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2016 (NCT02844881)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dendritic cells loaded with 17 antigens
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03034304 | Phase 1 | Jan 1, 2017 | HRYZ Biotech Co., Sun Yat-Sen University, SYZ Cell Therapy Co.. |
| NCT02844881 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2016 | Hengrui Therapeutics, Inc., The First People's Hospital of Lianyungang |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hengrui Therapeutics, Inc. | For profit | 1 | 0 | 1 | 2016 |
| HRYZ Biotech Co. | For profit | 1 | 0 | 1 | 2017 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| SYZ Cell Therapy Co.. | For profit | 1 | 1 | 1 | 2017 |
| The First People's Hospital of Lianyungang | Academic/Hospital | 1 | 1 | 1 | 2016 |
5 organizations
Page 1 / 1